Samyoung S&C possesses core talent, technology, and facilities for a full value chain—from semiconductor sensor fabrication and packaging to finished transmitters. Since developing Korea’s first resistive humidity sensor in 1993, the company has built advanced technologies in temperature, humidity, and pressure sensing, supported by cleanroom production, automated equipment, and precision measurement systems. Its sensors and instruments serve appliances, automotive, and industrial applications. Products are certified by major global electronics and automotive makers and managed under
SAMWOO MANUFACTURING CO.LTD
| KOREA / ALL PARTS FOR GUITAR / ‘SAMWOO’ was established in 1994 and has been providing the best quality and service until now.We supply a wide range of products to various customers worldwide, from guitar factories that require large quantities of parts to retailers, and we continuously update our offerings. We handle Korean-made parts, working with various factories that have expertise in each component, as well as a few select items directly linked to manufacturing strengths, and have grown steadily to date. Through constant updates, we are investing in R&D and collaborating with various major manufacturers. We would like to invite you to our booth! If you have any questions, please send an e-mail to SAMWOO@SWMUSIC.CO.KR or use the Contact us page on our website.
Samyang Chemical Group
Samyang Chemical Group(SCG), founded in 1975 in South Korea, delivers a sustainable future for our customers and communities. Through SCG’s years of experience, DREAUM was founded in 2019 as an investment arm of SCG that not only invest strategically but also financially into next generation mid-size enterprise.
Samyang Corp
Samyang Corporation is a leading manufacturer of food ingredients ranging from commodities to highly functional specialty ingredients. Almost a centennial’s experience and our R&D capabilities enable us to provide customized application solution to meet the specific needs of our customers. Food safety and high quality are always top priority to Samyang Corporation. As one of the most trusted companies in South Korea we are ready to be the partner for your success.
Samyang KCI
“Samyang KCI Corporation pioneers in personal care. High-quality raw materials, innovative products trusted worldwide. Come join us to discover your ultimate solutions!”
Samsung Electronics Co., Ltd. (C-Lab)
C-Lab is a Samsung-operated program designed to transform creative ideas into business opportunities and stimulate the South Korean start-up ecosystem, C-Lab began as an in-house idea incubation program in 2012 and expanded externally as C-Lab Outside in 2018.
Samsung Electronics
Samsung inspires the world and shapes the future with transformative technologies, driving innovation across TVs, smartphones, wearables, home appliances and network system, as well as memory, system LSI and foundry. The First Look pre-registration via link is required for the entry. Attendance is subject to capacity limits by time slot. | About Samsung Electronics Co., Ltd. Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry and LED solutions. For the latest news, please visit the Samsung Newsroom at news.samsung.com.
Samsung SDS
Samsung SDS offers integrated IT services and global logistics BPO in a diverse range of industries. Cloud-based IT services help private and public sector clients based on its experiences with Samsung affiliates and capabilities in digital technology. Logistics services support clients to manage and operate the entire logistics process.
Samsung Biologics
Samsung Biologics is a fully integrated end-to-end service provider offering development and manufacturing services, all at one site. We provide highly tailored solutions to clients, while meeting the evolving needs of the global healthcare industry. With proven regulatory approvals, Samsung Biologics is a trusted CDMO partner of choice and is uniquely able to provide seamless offerings from cell line development to final aseptic fill/finish for biologics. To maximize our operational efficiency and expand our capabilities in response to growing biomanufacturing demands, Samsung Biologics is constructing a fourth plant, which will further advance the company’s standing as the world’s largest manufacturing facility at a single site—holding a 604KL total capacity upon full completion in mid-2023. Our facilities are all cGMP compliant with bioreactors ranging from small to large scales. We continue to upgrade our capabilities to accommodate our clients by investing in single-use technology and additional aseptic filling capacity. Additionally, Samsung Biologics’ R&D Center in South San Francisco is equipped for high-quality cell line development, and our Sales Office in Ridgefield Park, New Jersey, enables the company to work in closer proximity to clients based in the U.S. and Europe. We are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing solutions, operational excellence, and proven expertise. Your Trusted CDMO Partner, Samsung Biologics | Samsung Biologics is a fully integrated CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry. With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products. Our plants are cGMP compliant with a wide range of bioreactor scales to serve varying client needs and meet growing market demand. We hold a total capacity of 604KL at Bio Campus I, the world’s largest biomanufacturing site, and have announced plans to construct a fifth plant, which will be operational in April 2025. | Samsung Biologics (KRX: 207940.KS) is a global contract development and manufacturing organization (CDMO), offering end-to-end integrated services that range from late discovery to commercial manufacturing. With a combined biomanufacturing capacity of 784kL across five plants, Samsung Biologics leverages its technologies and expertise to advance diverse modalities, including antibody-drug conjugates (ADC), multispecific antibodies, fusion proteins, and mRNA vaccines. With over 5,000 employees, Samsung Biologics operates a global network with facilities and offices in Korea, the U.S., and Japan. Samsung Biologics America facilitates support to clients based in the U.S. and Europe, while a sales office in Japan serves the APAC region. Samsung Biologics continues to invest in new capabilities to maximize operational and quality excellence, ensuring flexibility and agility for clients. The company is committed to the on-time, in-full delivery of high-quality products, as well as making sustainable business decisions for the betterment of society, global health, and the planet. For more information, please visit https://samsungbiologics.com/